Celtaxsys
Signal active
Organization
Contact Information
Overview
Celtaxsys, is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer, and inflammatory and autoimmune diseases. Its technology manipulates immune cell migration as a treatment for cancer, inflammation, and organ/tissue rejection. The company's drug compounds are designed to block the protective mechanisms created by certain tumors to prevent attack by immune system cells.
About
Industries
Biotechnology, Health Care, Biopharma
Founded
2004
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Celtaxsys headquartered in United States, North America, operates in the Biotechnology, Health Care, Biopharma sector. The company focuses on Biotechnology and has secured $5.5B in funding across 84 round(s). With a team of 11-50 employees, Celtaxsys is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - Celtaxsys, raised $4.2M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
7
Investors
0
Lead Investors
0
Total Funding Amount
$65.2M
Details
5
Celtaxsys has raised a total of $65.2M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2008 | Early Stage Venture | 3.7M | ||
| 2005 | Early Stage Venture | 5.2M | ||
| 2015 | Late Stage Venture | 45.0M | ||
| 2010 | Late Stage Venture | 4.2M |
Investors
Celtaxsys is funded by 17 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Celtaxsys | - | FUNDING ROUND - Celtaxsys | 45.0M |
| GRA Venture Fund | - | FUNDING ROUND - GRA Venture Fund | 45.0M |
| Celtaxsys | - | FUNDING ROUND - Celtaxsys | 45.0M |
| Domain Associates | - | FUNDING ROUND - Domain Associates | 45.0M |
Recent Activity
There is no recent news or activity for this profile.